Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Table 3 Referral to Hospice Palliative Care before (Group 1) and after (Group 2) the implementation of the Life-Sustaining Treatment Decisions Act

Variables	Group 1 (n = 943)	Group 2 (n = 891)	p-value
HPC referral	398 (42.2 %)	607 (68.1 %)	< 0.001
Consent to HPC^a	334 (83.9 %)	487 (80.2 %)	< 0.001
HPC referral to death, day (Mean ± SD)^a	36.5 ± 52.9	46.0 ± 79.5	0.035

^aanalyzed from cases referred to HPC (n = 1005; 398 from group 1, 607 from group 2)
HPC hospice palliative care; SD standard deviation

ISSN: 1472-684X